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(langerin) + Langerhans cells were present predominantly in the lower region of the epithelium and not 48 in the lamina propria (Fig. 1A) . Among isolated vaginal mononuclear cells (MNLs) (12, 14) that 49 expressed myeloid marker CD13, 9.1 ±3.0% (n=11) expressed DC marker CD11c, indicating a 50 myeloid DC population. Most vaginal CD13 + CD11c + DCs expressed HLA-DR, and a substantial 51 proportion expressed DC-SIGN, mannose receptor CD206, maturation marker CD83, co-stimulatory 52 molecule CD86, and lymph node homing receptor CCR7 (Fig. 1B) . Importantly, vaginal DCs also 53 expressed CD4 (36.6%), CCR5 (41.5%) and CXCR4 (31.4%), and a substantial proportion co-54 expressed CD4 plus CCR5 (19.7%) and CD4 plus CXCR4 (18.5%) (Fig. 1B,C) . Thus, vaginal 55 CD13 + CD11c + DCs express receptors that bind HIV-1 (12, 15-18). Except for DC-SIGN, the 56 percentage of vaginal DCs that express these receptors was significantly different from that of control 57 of freshly isolated human vaginal MNLs inoculated with YU2 Env-pseudotyped GFP-Gag virus-like 61 particles (VLPs) (19) at an MOI=10, VLPs were detected in 6.2% of CD13 + CD11c + DCs at 15 min, 62 increasing to 11.9% of the DCs at 2 h post-inoculation by flow cytometry gating on the CD13 + cells for 63
CD11c and GFP ( Fig. 2A) . Next, we determined the ability of isolated vaginal DCs to capture T/F 64 viruses. To more closely mimic natural transmission, we used a pre-determined optimal MOI=0.1 65 (from MOIs=0.01-1.0) for infectious T/F viruses. Among vaginal MNLs isolated from a representative 66 donor, 3.21% to 6.77% of the CD11c + DCs bound T/F viruses and 1.46% bound control YU2 at an 67 optimal MOI=0.1 at 2 h (Fig. 2B ). The T/F viruses CH040, CH058 and CH077, which were used in 68 these experiments, are subtype B viruses and were cloned from Fiebig stage II/III donors (20, 21) . 69
Vaginal CD11c + DCs from 10 different donors captured T/F viruses CH040, CH058 and CH077 1.5-, 70 1.6-and 1.8-fold, respectively, more efficiently compared with the capture of YU2 (p=0.028, 0.035 71 and 0.006, respectively) ( Fig. 2C) to naive T cells (25). Therefore, we determined whether vaginal DCs could capture HIV-1 inoculated 80 onto freshly constructed, leak-proof explants of vaginal mucosa, as we have previously described (14, 81 23), and transport the virus through the mucosa. YU2 or media were inoculated onto vaginal explants, 82 and 2 h later the cells that had migrated through the tissue into the lower chamber were collected and 83 analyzed for HIV-1 by flow cytometry gating on CD13 + CD11c + , CD13 + CD11cand CD3 + for DCs, 84 macrophages and lymphocytes, respectively, and using KC57-FITC to detect intracellular virus. 85
Among the cells in the lower chamber, only CD13 + CD11c + cells, and neither CD13 + CD11c -86 macrophages nor CD3 + lymphocytes, contained HIV-1 (Fig. 3A) . The migrating CD13 + CD11c + cells 87 also expressed HLA-DR, DC-SIGN, CD206, CD83, CD86 and CCR7 (data not shown). Thus, the 88 cells that capture and transport HIV-1 through vaginal mucosa within the first 2 h after inoculation are 89 myeloid DCs. We next inoculated the apical surface of explants with T/F viruses CH058 and CH077 90 and 2 h later detected both viruses in CD13 + CD11c + DCs in the lower chamber ( Fig. 3B ). In four 91 separate vaginal tissues, DCs captured and transported T/F virus CH058 1.7-fold and CH077 1.6-fold 92 more efficiently than chronic virus YU2 (Fig. 3C) . 93
Vaginal myeloid DCs efficiently transmit T/F HIV-1 in trans to lymphocytes. Having 94
shown that mDCs are the only lamina propria cells that capture and transport T/F HIV-1 through 95 explanted vaginal mucosa (Fig. 3) , we next explored whether the DCs that migrated through the 96 mucosa could transmit infectious virus to target mononuclear cells. YU2 HIV-1 was applied to the 97 apical surface of vaginal explants, and 2 h later cells that had migrated into the lower chamber were 98 collected and co-cultured with PHA-stimulated heterologous peripheral blood lymphocytes (PBLs) or 99 autologous vaginal lamina propria MNLs for up to 4 days, after which the cells were analyzed for 100
HIV-1 replication by flow cytometry, using KC57-FITC intracellular staining of CD3 + T cells and p24 101
ELISA. Cells that migrated into the lower chamber of explants inoculated with YU2, but not 102 supernatant or cells from media-inoculated explants, infected both blood ( Fig. 4A ) and vaginal T cells 103 
